Skip to content

Clinical trials

Phase 3 Pancreatic Neoplasms trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Phase: Phase 3 Country / region: Russia Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20062
20071
20091
20112
20141
20161
20181
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi2
AB Science1
Amgen1
Celgene1
GlaxoSmithKline1
NantCell, Inc.1
Sumitomo Pharma America, Inc.1
SynCore Biotechnology Co., Ltd.1
Threshold Pharmaceuticals1
Traws Pharma, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms11
Neoplasms3
Endocrine Gland Neoplasms2
Neoplasm Metastasis2
Adenocarcinoma1
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Pancreatic Ductal1
Colorectal Neoplasms1
Digestive System Diseases1
Digestive System Neoplasms1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.